| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/11/2010 | US20100063088 Raf Kinase Inhibitors |
| 03/11/2010 | US20100063036 Substituted morpholine and thiomorpholine derivatives |
| 03/11/2010 | US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders |
| 03/11/2010 | US20100062065 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system |
| 03/11/2010 | US20100059261 Reactive monomer and resin composition containing same |
| 03/11/2010 | US20100058650 Hydroxymethylfurfural ethers from sugars or hmf and mixed alcohols |
| 03/10/2010 | EP2161266A1 Benzofuran derivatives as orexin receptor antagonists |
| 03/10/2010 | EP2161252A1 N-Alkylcarbonyl-amino acid ester and N-Alkylcarbonyl-amino lactone compounds and their use |
| 03/10/2010 | EP2161251A1 Alcohol production method by reducing ester or lactone with hydrogen |
| 03/10/2010 | EP1896456B1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 03/10/2010 | CN101665477A (E)-3-(benzfuran-5-yl) acrylic ester compound, preparation method and application thereof |
| 03/10/2010 | CN101665476A Shaanxi dulcite A extracted from Shaanxi japonicas and extracting process thereof |
| 03/09/2010 | US7674938 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid |
| 03/09/2010 | US7674920 contacting, under reactive and anhydrous conditions, at least one halophthalic anhydride containing more than 250 ppm chlorophthalide impurity with an alkali metal carbonate in the presence of a phase transfer catalyst selected from hexaalkylguanidinium halides, phosphonium salts, phosphazenium salts |
| 03/09/2010 | US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 03/09/2010 | US7674825 Cardiovascular disorders; stimulant of guanylate cyclase |
| 03/09/2010 | US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 03/09/2010 | US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants |
| 03/09/2010 | US7674745 Formed by heating vanadium pentoxide suspended in liquid with solution of silver salt, and isolating the product; spray drying; filtering; drying; for production of catalysts for gas-phase partial oxidation of aromatic hydrocarbons |
| 03/09/2010 | US7674614 Method of optically resolving racemic alcohols with a bicyclooxaoctane or a bicycooxaoctene resolving reagents |
| 03/09/2010 | CA2482346C Substituted phenylacetamides and their use as glucokinase activators |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/04/2010 | WO2010025366A2 Method for forming allylic alcohols |
| 03/04/2010 | WO2010025179A1 1-(4-ureidobenzoyl)piperazine derivatives |
| 03/04/2010 | WO2010024769A1 New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 03/04/2010 | WO2010023448A1 Novel potassium channel blockers |
| 03/04/2010 | WO2010023445A1 Novel potassium channel blocker |
| 03/04/2010 | US20100056809 Ascorbic Acid Derivatives |
| 03/04/2010 | US20100056808 Prostaglandin synthesis and intermediates for use therein |
| 03/04/2010 | US20100056807 Prostaglandin synthesis and intermediates for use therein |
| 03/04/2010 | US20100056621 Agonists of a bitter taste receptor and uses thereof |
| 03/04/2010 | US20100056600 11beta-hsd1 active compounds |
| 03/04/2010 | US20100056528 Sulfonamide derivatives with therapeutic indications |
| 03/04/2010 | US20100050719 Chemicals promoting the growth of n-acylhomoserine lactone-degrading bacteria |
| 03/04/2010 | DE102008044890A1 Katalysator für die katalytische Gasphasenoxidation von aromatischen Kohlenwasserstoffen zu Aldehyden, Carbonsäuren und/oder Carbonsäureanhydriden, insbesondere zu Phthalsäureanhydrid, sowie Verfahren zur Herstellung eines solchen Katalysators Catalyst for the catalytic gas-phase oxidation of aromatic hydrocarbons to aldehydes, carboxylic acids and / or carboxylic anhydrides, in particular for phthalic anhydride, and processes for preparing such a catalyst |
| 03/04/2010 | CA2735497A1 New compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 03/04/2010 | CA2733661A1 1-(4-ureidobenzoyl)piperazine derivatives |
| 03/03/2010 | EP2159216A1 Ih - Modulators |
| 03/03/2010 | EP1828157B1 Method for producing alkenyl succinic anhydrides |
| 03/03/2010 | EP1313693B1 Two-stage process for the hydrogenation of maleic acid to 1,4-butanediol |
| 03/03/2010 | CN101659647A Method for preparing diphenyl tetracarboxylic dianhydride |
| 03/02/2010 | US7671219 Reacting a fullerene oxide and a carbonyl compound in the presence of a Lewis acid catalyst forming Fullerene 1,3-dioxolane; solar cells |
| 03/02/2010 | US7671201 Phenyl substituted cyclic derivatives |
| 03/02/2010 | US7671092 Paclitaxel enhancer compounds |
| 03/02/2010 | US7671088 Water-soluble etoposide analogs and methods of use thereof |
| 03/02/2010 | US7671087 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2010 | US7671075 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 03/02/2010 | US7671055 Insecticidal 3-(dihaloalkenyl) phenyl derivatives |
| 03/02/2010 | US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/02/2010 | CA2303767C Group 8, 9 or 10 transition metal catalyst for olefin polymerization |
| 02/28/2010 | CA2676759A1 Prostaglandin synthesis and intermediates for use therein |
| 02/28/2010 | CA2639240A1 Prostaglandin synthesis and intermediates for use therein |
| 02/25/2010 | WO2010022200A1 Method for preparing long-chain hydroxyacids, diacids and oligomers and polylmers thereof |
| 02/25/2010 | WO2010020556A1 New bradykinin b1 antagonists |
| 02/25/2010 | WO2009139593A3 Method for preparing chiral intermediates for preparation of hmg-coa reductase inhibitors |
| 02/25/2010 | US20100048924 Solvo-thermal hydrolysis of xylose |
| 02/25/2010 | US20100048922 Process for one-stage preparation of 2-methyltetrahydrofuran from furfural over two catalysts in a structured bed |
| 02/25/2010 | US20100048919 Method for Preparing Crystalline 3-0-Alkyl-Ascorbic Acid |
| 02/25/2010 | US20100048917 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048696 Agricultural disease control agent |
| 02/25/2010 | US20100048692 Naphthofuranone Derivatives as Specific Inhibitors of Thymidylate Synthases |
| 02/25/2010 | US20100048618 Derivatives of 8-epiblechnic Acid and their Effects on Down-Regulation of Endothelin (ETA) receptor mRNA |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | CA2771226A1 New bradykinin b1 antagonists |
| 02/25/2010 | CA2734893A1 Method for preparing long-chain hydroxyacids, diacids and oligomers and polymers thereof |
| 02/24/2010 | EP2155710A2 Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the s-isomer |
| 02/24/2010 | EP2155687A1 Diacylglycerol acyltransferase inhibitors |
| 02/24/2010 | EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 02/24/2010 | EP2155670A1 Anti -inflammatory substituted cyclobutenedione compounds |
| 02/24/2010 | EP2001873B1 Active ingredient combinations with insecticidal properties |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1458675B1 Alpha-cyanoacrylates |
| 02/24/2010 | EP1458674B1 Beta-amino-alpha-cyanoacrylates and their use as herbicides |
| 02/24/2010 | CN101654445A Compound for preparing ramelteon, preparation method thereof and application thereof |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/23/2010 | US7667078 Asymmetric reaction catalyst and method for preparing optically active compound using the same |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7666904 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
| 02/23/2010 | US7666866 Antithrombotic diamides |
| 02/23/2010 | US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/18/2010 | WO2010019646A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | WO2010018874A1 Amide compound |
| 02/18/2010 | US20100041904 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
| 02/18/2010 | US20100041889 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 02/18/2010 | US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
| 02/18/2010 | CA2733970A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/17/2010 | EP2153831A1 Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient |
| 02/17/2010 | EP2152683A1 Substituted amino-thiourea compounds for combating animal pests |
| 02/17/2010 | EP2152682A1 2,5-di- and 2,2,5-trisubstituted di- and tetrahydrofuran derivatives and their use for the production of perfumes |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101648932A 3,4-ring-opening polyacylation grayananes diterpene compound and preparation method thereof |